Surgery Partners (SGRY) Given News Sentiment Rating of 0.07
Headlines about Surgery Partners (NASDAQ:SGRY) have been trending somewhat positive on Wednesday, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Surgery Partners earned a news impact score of 0.07 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 47.3415951834781 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the news stories that may have effected Accern’s analysis:
- Surgery Partners, Inc. (SGRY) Lifted to Hold at Zacks Investment Research (americanbankingnews.com)
- ETFs with exposure to Surgery Partners, Inc. : October 13, 2017 (finance.yahoo.com)
- Contrasting Envision Healthcare Corp (AMSG) & Surgery Partners (SGRY) (americanbankingnews.com)
- Surgery Partners, Inc. (SGRY) Given Consensus Recommendation of “Hold” by Analysts (americanbankingnews.com)
Surgery Partners (NASDAQ:SGRY) traded down 4.71% during trading on Wednesday, reaching $9.10. 277,155 shares of the company were exchanged. The firm has a market cap of $444.18 million, a price-to-earnings ratio of 59.87 and a beta of 2.05. Surgery Partners has a 52-week low of $8.52 and a 52-week high of $24.05. The firm has a 50-day moving average of $9.90 and a 200-day moving average of $16.94.
SGRY has been the subject of a number of research reports. Raymond James Financial, Inc. restated a “market perform” rating on shares of Surgery Partners in a report on Wednesday, August 9th. BidaskClub cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Jefferies Group LLC restated a “buy” rating and set a $16.00 target price (down from $22.00) on shares of Surgery Partners in a report on Friday, September 8th. KeyCorp restated a “hold” rating on shares of Surgery Partners in a report on Friday, September 22nd. Finally, Zacks Investment Research upgraded shares of Surgery Partners from a “hold” rating to a “buy” rating and set a $22.00 target price for the company in a report on Wednesday, August 2nd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company’s stock. Surgery Partners presently has a consensus rating of “Hold” and an average target price of $19.29.
WARNING: “Surgery Partners (SGRY) Given News Sentiment Rating of 0.07” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/10/18/surgery-partners-sgry-given-news-sentiment-rating-of-0-07.html.
In related news, major shareholder H.I.G. Surgery Centers, Llc sold 26,455,651 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $19.00, for a total transaction of $502,657,369.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 7.60% of the stock is currently owned by insiders.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Stock Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related stocks with our FREE daily email newsletter.